CO88 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis
Abstract
Authors
W.P. Maksymowych H. Thom M. Mørup V. Taieb D. Willems K. Gaffney